Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis Presenting with An Atypical, Protracted Course of Cognitive Decline
Authors:
Open Access
- 10 June 2026
- journal article
- Published by Korean Epilepsy Society in Journal of Epilepsy Research
- Vol. 16 (1) , 41-44
Abstract
Autoimmune encephalitis typically presents with an acute or subacute onset of cognitive decline, altered mental status, and seizures. Here, we report a case of anti-leucine-rich glioma-inactivated 1 encephalitis characterized by an atypically protracted period of cognitive decline, followed by the delayed onset of seizures. We describe the clinical characteristics, unique neuroimaging findings, and the patient’s response to treatment. By discussing the implications of this unusual clinical trajectory, we aim to enhance diagnostic awareness and prevent potential misdiagnosis in cases with atypically prolonged presentations.Keywords
This publication has 15 references indexed in Scilit:
- Magnetic Resonance Imaging Characteristics of LGI1-Antibody and CASPR2-Antibody EncephalitisJAMA Neurology, 2024
- Syndrome of Inappropriate Antidiuresis: From Pathophysiology to ManagementEndocrine Reviews, 2023
- Infectious diseases and cognition: do we have to worry?Neurological Sciences, 2022
- Rapidly progressive dementias — aetiologies, diagnosis and managementNature Reviews Neurology, 2022
- Tics in patients with encephalitisNeurological Sciences, 2021
- Posterior reversible encephalopathy syndrome as initial manifestation of autoimmune encephalitisNeurology Clinical Practice, 2019
- Movement disorders associated with neuronal antibodiesActa Neurologica Scandinavica, 2018
- The Laboratory Diagnosis of Autoimmune EncephalitisJournal of Epilepsy Research, 2016
- Progressive cognitive impairment after strokeJournal of Stroke and Cerebrovascular Diseases, 2004
- Interleukin-6 Induces Oxidative Stress and Endothelial Dysfunction by Overexpression of the Angiotensin II Type 1 ReceptorCirculation Research, 2004